Work With Your Doctor to Get Jaypirca (Pirtobrutinib) Approved by Cigna in North Carolina: Complete Prior Authorization Guide
Answer Box: Getting Jaypirca (Pirtobrutinib) Covered by Cigna in North Carolina
Cigna requires prior authorization for Jaypirca (pirtobrutinib), a specialty BTK inhibitor for relapsed mantle cell lymphoma or CLL/SLL after prior BTK inhibitor failure. Your doctor must submit clinical documentation proving prior therapy failures and medical necessity through Accredo